Read articles from Global

August 04, 2026 by substack.com

Quitting nicotine and quitting smoking are not the same public health outcome. A person may continue using nicotine while dramatically reducing exposure to the toxicants created by burning tobacco. That distinction matters because insisting on nicotine abstinence as the only acceptable goal can overlook meaningful reductions in disease risk. For many smokers, the first priority should be leaving combustion behind — even if nicotine use does not end immediately.

August 04, 2026 by substack.com

Sometimes harm reduction begins with one person who refuses to give up on someone else. Behind the evidence, policy arguments and product categories are people who smoke, people who love them, and people trying to keep them alive long enough to find a safer path. Tobacco harm reduction is often discussed as a technical issue, but its urgency is deeply human. The goal is not to win an argument about nicotine — it is to reduce harm for real people.

August 04, 2026 by gfn.tv

Stability may sound like a technical detail, but it shapes whether a nicotine pouch performs consistently over time. Formula design can affect nicotine release, shelf life, user experience and the standards regulators should expect from smoke-free products. That makes product chemistry part of the public health conversation, not just a manufacturing issue. If nicotine pouches are to be regulated responsibly, evidence on formulation and stability should matter as much as assumptions about the category.

August 03, 2026 by vapingpost.com

A nicotine pouch is not a cigarette without smoke; it is a different product category altogether. That distinction matters for regulation, because rules designed around combustion do not automatically make sense for oral, smoke-free nicotine. Pouches still need standards, age controls and monitoring, but policy should reflect their actual risk profile rather than the stigma attached to cigarettes. Regulation is most credible when it recognises differences instead of flattening them.

July 31, 2026 by gfn.tv

Prohibition can give the impression of control while making the underlying risks harder to manage. When legal access to safer nicotine products is restricted, demand does not disappear; it can shift towards illicit supply, misinformation or continued cigarette use. That is where public health loses ground: not in the intention to reduce harm, but in the failure to account for real-world behaviour. Effective policy should reduce risk where people actually are, not where theory assumes they should be.

July 31, 2026 by substack.com

Safer nicotine did not appear out of nowhere. Its history is shaped by smokers looking for alternatives, scientists measuring risk, and policies that often struggled to keep up with both. From snus to vaping and nicotine pouches, the same lesson keeps returning: removing combustion can change the health equation. Understanding that history matters, because the future of tobacco policy should not repeat the mistakes that kept cigarettes at the centre for so long.

July 30, 2026 by clearingtheair.eu

The most “terrifying” thing about nicotine may be how poorly it is understood. Public fear often focuses on nicotine itself, while the far greater danger comes from inhaling smoke produced by combustion. That misunderstanding has consequences: smokers may avoid lower-risk alternatives because they believe nicotine is the main cause of smoking-related disease. Better public health communication should separate dependence from harm, and fear from evidence.

July 30, 2026 by gfn.tv

What is actually inside a nicotine pouch matters more than the assumptions around it. Ingredients, formulation and exposure need to be examined transparently, especially as pouches become part of the wider harm reduction debate. Scrutiny is necessary, but it should be specific: what is in the product, how it is used, and how its risks compare with combustible tobacco. Good regulation starts with chemistry and evidence, not suspicion by category.

July 28, 2026 by gfn.tv

Harm reduction cannot only reach the people easiest to reach. Marginalised communities often face the highest burden of smoking-related harm, while also having less access to trusted healthcare, stable support and practical quitting routes. Tobacco harm reduction has to be built with those realities in mind: affordable options, credible messengers and policies that do not add stigma to disadvantage. Reducing harm means reaching the people public health too often misses.

July 27, 2026 by substack.com

High-powered vaping devices are easy to frame as alarming because they produce more vapour and use more energy. But risk cannot be judged by appearance alone. The safety question depends on measured emissions, exposure conditions, device operation and how results compare with continued smoking. Sub-ohm vaping should be assessed through data and realistic use patterns, not assumptions that bigger clouds automatically mean greater harm.